We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.22%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$79.7B
AUM Growth
+$3.42B
(+4.5%)
Cap. Flow
-$854M
Cap. Flow
% of AUM
-1.07%
Top 10 Holdings %
Top 10 Hldgs %
14.29%
Holding
1,817
New
122
Increased
851
Reduced
711
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson Controls International
JCI
|
+$281M |
| 2 |
Comcast
CMCSA
|
+$235M |
| 3 |
Apple
AAPL
|
+$172M |
| 4 |
MetLife
MET
|
+$151M |
| 5 |
Mid-America Apartment Communities
MAA
|
+$148M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$399M |
| 2 |
UBS Group
UBS
|
+$393M |
| 3 |
Televisa
TV
|
+$305M |
| 4 |
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
|
+$278M |
| 5 |
New Oriental
EDU
|
+$169M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 15.42% |
| 2 | Financials | 13.04% |
| 3 | Healthcare | 11.98% |
| 4 | Consumer Discretionary | 11.9% |
| 5 | Technology | 10.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Burlington
BURL
$22B
| $82.6M | 0.1% |
1,019,531
-33,995
| -3% | -$2.63M |
|
|
FTRPR
227
DELISTED
Frontier Communications Corporation 11.125% Series A Mandatory Convertible Preferred Stock
FTRPR
| $82M | 0.1% |
976,850
+113,825
| +13% | +$10.5M |
|
228
General Motors
GM
$74.7B
| $81.4M | 0.1% |
2,560,977
-423,713
| -14% | -$13.2M |
|
229
USA Compression Partners
USAC
$3.82B
| $81.1M | 0.1% |
4,316,727
+648,313
| +18% | +$10.3M |
|
230
Paylocity
PCTY
$6.71B
| $80.8M | 0.1% |
1,818,480
-57,719
| -3% | -$2.56M |
|
231
Ford
F
$57.3B
| $80.6M | 0.1% |
6,677,352
-357,165
| -5% | -$4.51M |
|
232
Ionis Pharmaceuticals
IONS
$9.35B
| $80.4M | 0.1% |
2,193,626
+307,175
| +16% | +$9.61M |
|
233
Synopsys
SNPS
$71.5B
| $78.9M | 0.1% |
1,329,090
-20,626
| -2% | -$1.17M |
|
234
Xylem
XYL
$28.5B
| $78.6M | 0.1% |
1,499,025
-97
| -0% | -$4.76K |
|
|
ACC
235
DELISTED
American Campus Communities, Inc.
ACC
| $78.6M | 0.1% |
1,545,485
+343,451
| +29% | +$17.6M |
|
236
Royal Gold
RGLD
$17.1B
| $77.7M | 0.1% |
1,003,113
+521,733
| +108% | +$41.9M |
|
|
BCR
237
DELISTED
CR Bard Inc.
BCR
| $77.6M | 0.1% |
345,954
+313,624
| +970% | +$70.6M |
|
238
Abbott
ABT
$180B
| $77.4M | 0.1% |
1,830,681
+694,919
| +61% | +$29.8M |
|
239
Cognex
CGNX
$10.3B
| $77.1M | 0.1% |
2,917,854
+9,332
| +0.3% | +$224K |
|
|
GMLP
240
DELISTED
Golar LNG Partners LP
GMLP
| $76.9M | 0.1% |
3,918,686
+349,835
| +10% | +$6.62M |
|
241
Occidental Petroleum
OXY
$57B
| $76.8M | 0.1% |
1,053,804
-288,558
| -21% | -$21.6M |
|
242
CAE Inc. Common Shares
CAE
$8.1B
| $76.7M | 0.1% |
5,402,887
+52,839
| +1% | +$718K |
|
243
Westlake Chemical Partners
WLKP
$777M
| $76.7M | 0.1% |
3,359,040
+96,763
| +3% | +$2.2M |
|
244
Newell Brands
NWL
$2.16B
| $76M | 0.1% |
1,443,362
+1,431,073
| +11,645% | +$74M |
|
245
Bruker
BRKR
$9.2B
| $75.9M | 0.1% |
3,350,970
+10,440
| +0.3% | +$239K |
|
|
SGEN
246
DELISTED
Seagen Inc. Common Stock
SGEN
| $75.6M | 0.09% |
1,400,000
| – | – |
|
|
PFPT
247
DELISTED
Proofpoint, Inc.
PFPT
| $74.6M | 0.09% |
997,179
-143,633
| -13% | -$10.6M |
|
248
Enbridge
ENB
$124B
| $74.5M | 0.09% |
1,684,618
+530,329
| +46% | +$22.2M |
|
249
MarketAxess Holdings
MKTX
$4.15B
| $74.2M | 0.09% |
448,343
-52,070
| -10% | -$8.46M |
|
250
Costco
COST
$415B
| $74M | 0.09% |
485,429
+84,423
| +21% | +$13.6M |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q3 2016 Portfolio in Review
As of Q3 2016, OppenheimerFunds held 1,817 positions worth $79.7B, up 4.5% from $76.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
OppenheimerFunds's Q3 2016 filing shows 122 new, 851 increased, 711 reduced and 96 closed positions. Its largest new stake was Fomento Económico Mexicano: 1,462,419 shares worth $135M. The largest sale was Bristol-Myers Squibb, an estimated $399M.
By sector, the portfolio is most concentrated in Energy at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- OppenheimerFunds's largest Q3 2016 buy was Fomento Económico Mexicano: 1,462,419 shares worth $135M.
- OppenheimerFunds added most to Johnson Controls International in Q3 2016, an estimated $281M increase.
- OppenheimerFunds's biggest Q3 2016 reduction was Bristol-Myers Squibb, cutting an estimated $399M.
- OppenheimerFunds fully exited UBS Group in Q3 2016, selling an estimated $393M.
- OppenheimerFunds's ten largest holdings make up 14% of its $79.7B portfolio in Q3 2016.
- OppenheimerFunds opened 122 new positions and closed 96 in Q3 2016.
- OppenheimerFunds's portfolio value rose 4.5% quarter-over-quarter to $79.7B.
Based on OppenheimerFunds's 13F filing for Q3 2016, filed 14 Nov 2016.